Susquehanna analyst James Friedman lowered the firm’s price target on Endava to $100 from $104 and keeps a Positive rating on the shares. The firm hosted Endava recently and came away encouraged about the company position over the long haul. Our sense is that industry uncertainty persists and so we trimmed September estimates modestly for conservatism and subsequnetly our price target.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on DAVA: